Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 10, Pages 2443-2448
Publisher
Proceedings of the National Academy of Sciences
Online
2018-02-21
DOI
10.1073/pnas.1722627115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide
- (2017) Erik Lee Snapp et al. eLife
- The HIV glycan shield as a target for broadly neutralizing antibodies
- (2015) Katie J. Doores FEBS Journal
- Conserved Molecular Signatures in gp120 Are Associated with the Genetic Bottleneck during Simian Immunodeficiency Virus (SIV), SIV-Human Immunodeficiency Virus (SHIV), and HIV Type 1 (HIV-1) Transmission
- (2015) Mileidy W. Gonzalez et al. JOURNAL OF VIROLOGY
- HIV-1 Envelope Glycan Moieties Modulate HIV-1 Transmission
- (2014) R. Shen et al. JOURNAL OF VIROLOGY
- Phenotypic properties of transmitted founder HIV-1
- (2013) N. F. Parrish et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV: Cell Binding and Entry
- (2013) C. B. Wilen et al. Cold Spring Harbor Perspectives in Medicine
- An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
- (2011) G. Ferrari et al. JOURNAL OF VIROLOGY
- Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry
- (2011) E. P. Go et al. JOURNAL OF VIROLOGY
- Broad neutralization coverage of HIV by multiple highly potent antibodies
- (2011) Laura M. Walker et al. NATURE
- A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity
- (2011) Mohammed Asmal et al. PLoS One
- Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
- (2011) S. Gnanakaran et al. PLoS Pathogens
- Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization
- (2010) J. M. Binley et al. JOURNAL OF VIROLOGY
- Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
- (2009) M. S. Seaman et al. JOURNAL OF VIROLOGY
- Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants
- (2009) M.-R. Abrahams et al. JOURNAL OF VIROLOGY
- The integrin 4 7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1
- (2009) C. Cicala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Genetic and antigenic features of the transmitted virus
- (2009) Brandon F Keele et al. Current Opinion in HIV and AIDS
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Viral characteristics of transmitted HIV
- (2008) Cynthia A Derdeyn et al. Current Opinion in HIV and AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started